SERPINE1 and esophageal squamous cell carcinoma: In addition, PAI-1-producing TAMs promote oxaliplatin resistance in colorectal cancer, while cisplatin activates CAFs in esophageal squamous cell carcinoma to increase PAI-1 secretion, thereby conferring cisplatin resistance [40].